MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-3.74
↑ 99% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthElevated
Average
-330.14
Historical baseline
PeriodValueYoY Change
2025-3.74+86.9%
2024-28.62+65.3%
2023-82.39-1235.5%
2022-6.17+9.4%
2021-6.81+99.6%
2020-1853.11-